4.7 Article

Association of Gamma-Aminobutyric Acid A Receptor α2 Gene (GABRA2) with Alcohol Use Disorder

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 39, Issue 4, Pages 907-918

Publisher

SPRINGERNATURE
DOI: 10.1038/npp.2013.291

Keywords

addiction; gamma-aminobutyric acid receptor; association; meta-analysis; susceptibility gene

Funding

  1. Lilly
  2. Lundbeck
  3. AbbVie
  4. Pfizer

Ask authors/readers for more resources

Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter in mammalian brain. GABA receptor are involved in a number of complex disorders, including substance abuse. No variants of the commonly studied GABA receptor genes that have been associated with substance dependence have been determined to be functional or pathogenic. To reconcile the conflicting associations with substance dependence traits, we performed a meta-analysis of variants in the GABA(A) receptor genes (GABRB2, GABRA6, GABRA1, and GABRG2 on chromosome 5q and GABRA2 on chromosome 4p12) using genotype data from 4739 cases of alcohol, opioid, or methamphetamine dependence and 4924 controls. Then, we combined the data from candidate gene association studies in the literature with two alcohol dependence (AD) samples, including 1691 cases and 1712 controls from the Study of Addiction: Genetics and Environment (SAGE), and 2644 cases and 494 controls from our own study. Using a Bonferroni-corrected threshold of 0.007, we found strong associations between GABRA2 and AD (P=9 x 10(-6) and odds ratio (OR) 95% confidence interval (CI) = 1.27 (1.15, 1.4) for rs567926, P = 4 x 10(-5) and OR = 1.21 (1.1, 1.32) for rs279858), and between GABRG2 and both dependence on alcohol and dependence on heroin (P=0.0005 and OR = 1.22 (1.09, 1.37) for rs211014). Significant association was also observed between GABRA6 rs321915I and AD. The GABRA2 rs279858 association was observed in the SAGE data sets with a combined P of 9 x 10(-6) (OR = 1.17 (1.09, 1.26)). When all of these data sets, including our samples, were meta-analyzed, associations of both GABRA2 single-nucleotide polymorphisms remained (for rs567926, P = 7 x 10(-5) (OR = 1.18 (1.09, 1.29)) in all the studies, and P = 8 x 10(-6) (OR = 1.25 (1.13, 1.38)) in subjects of European ancestry and for rs279858, P=5 x 10(-6) (OR=1.18 (1.1, 1.26)) in subjects of European ancestry. Findings from this extensive meta-analysis of five GABA(A) receptor genes and substance abuse support their involvement (with the best evidence for GABRA2) in the pathogenesis of AD. Further replications with larger samples are warranted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial

Victoria R. R. Votaw, Katie Witkiewitz, M. Lee Van Horn, Richard C. C. Crist, Timothy Pond, Henry R. R. Kranzler

Summary: This study aimed to investigate whether a single-nucleotide polymorphism (rs2832407) in GRIK1 moderates the effects of topiramate treatment for drinking reduction. The results showed that topiramate treatment was effective in reducing daily heavy drinking and desire to drink, and this effect was not influenced by the rs2832407*C-allele homozygotes.

ADDICTION (2023)

Article Biochemistry & Molecular Biology

Dissecting the epigenomic differences between smoking and nicotine dependence in a veteran cohort

Sheila Tiemi Nagamatsu, Robert H. Pietrzak, Ke Xu, John H. Krystal, Joel Gelernter, Janitza Liz Montalvo-Ortiz

Summary: Smoking is a serious public health issue that causes over 8 million deaths annually and can lead to nicotine dependence. This study examined the epigenomic signatures of nicotine dependence and identified specific biomarkers that can differentiate it from smoking exposure.

ADDICTION BIOLOGY (2023)

Editorial Material Substance Abuse

Announcing a name change for ACER

Henry R. R. Kranzler

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Substance Abuse

Does polygenic risk for substance-related traits predict ages of onset and progression of symptoms?

Henry R. R. Kranzler, Richard Feinn, Heng Xu, Brendan L. L. Ho, Divya Saini, Olivia R. R. Nicastro, Anya Jacoby, Sylvanus Toikumo, Joel Gelernter, Emily E. E. Hartwell, Rachel L. L. Kember

Summary: This study investigated the impact of genetic risk for substance use disorders (SUDs) on the onset and progression of substance use. The results showed that European-ancestry individuals and males had an earlier onset and quicker progression of substance use, and the polygenic risk scores (PRSs) had predictive value for substance use milestones and symptom progression. In African-ancestry individuals, PRSs also predicted some substance use milestones, albeit to a lesser extent due to a smaller discovery sample.

ADDICTION (2023)

Article Substance Abuse

Identifying genetic loci and phenomic associations of substance use traits: A multi-trait analysis of GWAS (MTAG) study

Heng Xu, Sylvanus Toikumo, Richard C. Crist, Klaudia Glogowska, Zeal Jinwala, Joseph D. Deak, Amy C. Justice, Joel Gelernter, Emma C. Johnson, Henry R. Kranzler, Rachel L. Kember

Summary: This study used multi-trait analysis to identify novel loci associated with substance use disorders in European and African populations. The results showed that multi-trait analysis can improve the genetic modeling of substance use traits and uncover genes that were not previously linked to substance use. Additionally, it enhanced the effectiveness of polygenic risk scores.

ADDICTION (2023)

Article Substance Abuse

Effects of topiramate therapy on serum bicarbonate concentration in a sample of 10,279 veterans

Michelle S. S. Naps, Shirley H. H. Leong, Emily E. E. Hartwell, Christopher T. T. Rentsch, Henry R. R. Kranzler

Summary: This study investigated the effects of topiramate, a medication used to treat alcohol use disorder, on serum bicarbonate concentrations. The study found that the effects of the medication on bicarbonate concentrations were similar regardless of the presence of alcohol use disorder or the dosage of topiramate. Therefore, it is recommended to monitor baseline and periodic serum bicarbonate concentrations during topiramate therapy.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Review Substance Abuse

Medications for treating alcohol use disorder: A narrative review

Henry R. Kranzler, Emily E. Hartwell

Summary: Chronic heavy alcohol use has negative impacts on neurotransmitter systems and causes various medical, psychiatric, and social problems. Evidence-based medications for treating alcohol use disorder (AUD) are not widely used in clinical practice. Pharmacogenetic approaches have gained interest but have not yet yielded strong enough results for routine clinical care.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Behavioral Sciences

Multi-omics cannot replace sample size in genome-wide association studies

David A. A. Baranger, Alexander S. Hatoum, Renato Polimanti, Joel Gelernter, Howard J. Edenberg, Ryan Bogdan, Arpana Agrawal

Summary: The integration of multi-omics information can be useful for interpreting findings from GWAS, but it does not reliably increase novel gene discovery in brain-related GWAS.

GENES BRAIN AND BEHAVIOR (2023)

Article Psychiatry

Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program

Youshu Cheng, Cecilia Dao, Hang Zhou, Boyang Li, Rachel L. Kember, Sylvanus Toikumo, Hongyu Zhao, Joel Gelernter, Henry R. Kranzler, Amy C. Justice, Ke Xu

Summary: Smoking behaviors and alcohol use disorder commonly co-occur and are moderately heritable. Previous single-trait GWAS studies have identified multiple loci for smoking and AUD. However, limited by small samples, GWASs aiming to identify loci contributing to co-occurring smoking and AUD have been less informative. Using multi-trait analysis of GWASs (MTAG) with data from the Million Veteran Program, this study identified novel loci associated with smoking initiation and cessation. Functional annotation highlighted biologically important regions contributing to smoking behaviors. MTAG results did not enhance discovery for smoking behaviors and alcohol consumption compared to single-trait GWAS. This study provides new insights into the pleiotropic effects of genetic variants on smoking behavior and AUD through the application of MTAG.

TRANSLATIONAL PSYCHIATRY (2023)

Review Substance Abuse

Metabolic Profiles Associated with Opioid Use and Opioid Use Disorder: a Narrative Review of the Literature

Juliana I. Byanyima, Xinyi Li, Sianneh A. Vesslee, Henry R. Kranzler, Zhenhao Shi, Corinde E. Wiers

Summary: Opioid use disorder (OUD) is a chronic condition with serious adverse consequences, including high incarceration rates and overdose-related fatalities. Medications used for OUD treatment have been shown to cause metabolic impairments, but the effects vary depending on the individual's metabolic condition. Further research is needed to determine the best approach for reducing the risk of metabolic disorders in OUD treatment.

CURRENT ADDICTION REPORTS (2023)

Article Substance Abuse

Polygenic risk score for problematic alcohol use predicts heavy drinking and alcohol use disorder symptoms in young adulthood after accounting for adolescent alcohol use and parental alcohol use disorder

Frances L. Wang, Brian M. Hicks, Hang Zhou, Henry R. Kranzler, Joel Gelernter, Robert A. Zucker

Summary: Genome-wide association studies (GWAS) have identified hundreds of loci associated with alcohol-related traits. This study aims to evaluate the usefulness of a polygenic risk score (PRS) for problematic alcohol use (PAU), and the results show that PAU PRS can predict heavy drinking and alcohol problems even after accounting for family history of AUD and prior drinking history.

DRUG AND ALCOHOL DEPENDENCE (2023)

Article Biochemistry & Molecular Biology

Loneliness and depression: bidirectional mendelian randomization analyses using data from three large genome-wide association studies

David A. Sbarra, Ferris A. Ramadan, Karmel W. Choi, Jorien L. Treur, Daniel F. Levey, Robyn E. Wootton, Murray B. Stein, Joel Gelernter, Yann C. Klimentidis

Summary: This study using Mendelian Randomization (MR) found robust evidence for a bidirectional causal relationship between loneliness and major depression (MD). The findings suggest that reducing loneliness may play a causal role in decreasing the risk for depressive illness, highlighting the importance of efforts to reduce loneliness in preventing and ameliorating MD.

MOLECULAR PSYCHIATRY (2023)

Article Neurosciences

Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge

Amanda J. F. Tamman, Dora Koller, Sheila Nagamastu, Brenda Cabrera-Mendoza, Chadi Abdallah, John H. Krystal, Joel Gelernter, Janitza L. Montalvo-Ortiz, Renato Polimanti, Robert H. Pietrzak

Summary: This study examined the association between GrimAge and genetic predisposition for systemic inflammation, as well as the moderating effect of psychosocial factors. The results showed that certain inflammatory markers were associated with accelerated GrimAge, and this association was influenced by modifiable psychosocial variables such as exercise and gratitude. Furthermore, gene enrichment analysis identified potential anti-inflammatory and antihistamine drugs that affect genes represented in the inflammatory markers.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

Gregory L. Rompala, Sheila T. Nagamatsu, Jose Jaime Martinez-Magana, Diana L. Nunez-Rios, Jiawei Wang, Matthew J. Girgenti, John H. Krystal, Joel Gelernter, Traumatic Stress Brain Res Grp, Yasmin L. Hurd, Janitza L. Montalvo-Ortiz

Summary: In this study, the authors revealed DNA hydroxymethylation as an important gene regulatory mechanism for OUD in the human brain using a multi-omics approach. They found that DNA hydroxymethylation showed a higher correlation with OUD-associated genes and gene networks compared to DNA methylation. The results also showed enrichment of DNA hydroxymethylation marks for GWAS of psychiatric traits and interactions with opioid-related drugs.

NATURE COMMUNICATIONS (2023)

Article Substance Abuse

Demographic differences in the cascade of care for unhealthy alcohol use: A cross-sectional analysis of data from the 2015-2019 National Survey on Drug Use and Health

Carrie M. Mintz, Justin Knox, Sarah M. Hartz, Deborah S. Hasin, Silvia S. Martins, Henry R. Kranzler, Emily Greene, Elvin H. Geng, Richard A. Grucza, Laura J. Bierut

Summary: This study analyzed demographic disparities in the implementation of SBIRT for unhealthy alcohol use. The results showed that gender, age, race, and insurance status were factors that influenced the likelihood of screening and intervention. Addressing these disparities and reducing attrition from treatment could improve outcomes for individuals with unhealthy alcohol use.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

No Data Available